Rumiko Shimazawa

Isehara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

An Evaluation of Foreign Clinical Data in the Approval Reviews of Antimicrobial Medicines in Japan: Considering Ethnic and Regional Differences in Data Extrapolations in Accordance With Regulatory Circumstances.

An Evaluation of Foreign Clinical Data in the Approval Reviews of Antimicrobial Medicines in Japan: Considering Ethnic and Regional Differences in Data Extrapolations in Accordance With Regulatory Circumstances.

Journal: Pharmacology research & perspectives

Published: March 10, 2026

Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data.

Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data.

Journal: British journal of clinical pharmacology

Published: March 11, 2025

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).

Journal: Journal of pharmaceutical policy and practice

Published: May 09, 2021

Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison.

Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison.

Journal: British journal of clinical pharmacology

Published: September 01, 2020

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.

Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.

Journal: Expert review of molecular diagnostics

Published: February 18, 2020

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Journal: Journal of pharmaceutical policy and practice

Published: January 25, 2019

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Journal: Journal of general and family medicine

Published: January 15, 2019

Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.

Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.

Journal: Pharmacology research & perspectives

Published: May 31, 2018

Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.

Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.

Journal: Journal of clinical pharmacy and therapeutics

Published: October 19, 2017

Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study.

Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study.

Journal: Journal of pharmaceutical policy and practice

Published: August 19, 2016

Overcoming regulatory challenges in the development of companion diagnostics for monitoring and safety.

Overcoming regulatory challenges in the development of companion diagnostics for monitoring and safety.

Journal: Personalized medicine

Published: March 01, 2016

Drug-diagnostic co-development: challenges and issues.

Drug-diagnostic co-development: challenges and issues.

Journal: Expert review of molecular diagnostics

Published: December 15, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026